Best practice management of patients with chronic obstructive pulmonary disease: A case-based review
dc.contributor.author | Vega-Olivo, M | |
dc.contributor.author | Halpin, DMG | |
dc.contributor.author | Han, MK | |
dc.contributor.author | Hanania, NA | |
dc.contributor.author | Kalhan, R | |
dc.contributor.author | Lipson, DA | |
dc.contributor.author | MacIntyre, N | |
dc.contributor.author | Midwinter, D | |
dc.contributor.author | Stiegler, M | |
dc.contributor.author | Young, C | |
dc.contributor.author | Martinez, FJ | |
dc.contributor.author | Criner, GJ | |
dc.date.accessioned | 2023-06-21T11:03:15Z | |
dc.date.issued | 2022-07-14 | |
dc.date.updated | 2023-06-20T09:13:29Z | |
dc.description.abstract | Chronic obstructive pulmonary disease (COPD) is associated with a high clinical and economic burden and is the fourth leading cause of death in the United States. The management of patients with COPD aims to minimize and control symptoms, prevent exacerbations, and improve quality of life. We provide an illustrated case study of a female patient with typical progression of COPD and describe the diagnosis, assessment, and management strategy, referring to the evidence seen in recent studies that supports the treatment decisions. | en_GB |
dc.description.sponsorship | GlaxoSmithKline | en_GB |
dc.description.sponsorship | GlaxoSmithKline | en_GB |
dc.description.sponsorship | National Institute of Health | en_GB |
dc.description.sponsorship | National Heart, Lung and Blood Institute | en_GB |
dc.format.extent | 730-735 | |
dc.identifier.citation | Vol. 18, No. 7, pp. 730-735 | en_GB |
dc.identifier.doi | https://doi.org/10.1016/j.nurpra.2022.03.010 | |
dc.identifier.grantnumber | CTT116855 | en_GB |
dc.identifier.grantnumber | NCT02164513 | en_GB |
dc.identifier.uri | http://hdl.handle.net/10871/133453 | |
dc.identifier | ORCID: 0000-0003-2009-4406 (Halpin, David MG) | |
dc.identifier | ScopusID: 57419799500 | 7005149597 (Halpin, David MG) | |
dc.language.iso | en | en_GB |
dc.publisher | Elsevier | en_GB |
dc.rights | © 2022 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/) | en_GB |
dc.subject | bronchodilator | en_GB |
dc.subject | COPD | en_GB |
dc.subject | inhaled corticosteroid | en_GB |
dc.subject | symptom | en_GB |
dc.title | Best practice management of patients with chronic obstructive pulmonary disease: A case-based review | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2023-06-21T11:03:15Z | |
dc.identifier.issn | 1555-4155 | |
dc.description | This is the final version. Available from Elsevier via the DOI in this record. | en_GB |
dc.identifier.eissn | 1878-058X | |
dc.identifier.journal | The Journal for Nurse Practitioners | en_GB |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | en_GB |
dcterms.dateAccepted | 2022-03-17 | |
rioxxterms.version | VoR | en_GB |
rioxxterms.licenseref.startdate | 2022-07-14 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2023-06-21T10:58:00Z | |
refterms.versionFCD | VoR | |
refterms.dateFOA | 2023-06-21T11:03:20Z | |
refterms.panel | A | en_GB |
refterms.dateFirstOnline | 2022-07-14 |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © 2022 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)